BioCentury | Feb 1, 2020
Translation in Brief
Preclinical Roundup: CureVac gets CEPI funding for 2019 coronavirus; plus blockade of CD47-SIRPA for atherosclerosis, Stanford and IBM-CDHI
CureVac gets CEPI funding for 2019 coronavirus The Coalition for Epidemic Preparedness Innovations and CureVac AG are extending a February 2019 collaboration to include a vaccine against the 2019-nCoV acute respiratory disease. The company will...